1. A method for processing an enhanced physical downlink control channel (EPDCCH), the method comprising:
notifying a user equipment (UE) of M physical resource block (PRB) sets used for EPDCCH transmission and N reference signal (RS) configurations used for EPDCCH downlink control information (DCI) rate matching andor EPDCCH resource mapping, and notifying the UE of correspondence between the M PRB sets and the N RS configurations, wherein N is a positive integer greater than 1, and M is a positive integer; and
performing the EPDCCH DCI rate matching andor the EPDCCH resource mapping according to the correspondence between the M PRB sets and the N RS configurations.
2. The method according to claim 1, wherein performing the EPDCCH DCI rate matching andor the EPDCCH resource mapping according to the correspondence between the M PRB sets and the N RS configurations comprises:
determining at least one RS configuration of the N RS configurations; and
performing the EPDCCH DCI rate matching andor the EPDCCH resource mapping according to the at least one RS configuration and a PRB set corresponding to the at least one RS configuration.
3. The method according to claim 1 wherein the correspondence between the M PRB sets and the N RS configurations comprises that the M PRB sets correspond to the N RS configurations in a one-to-one manner.
4. The method according to claim 1, wherein each RS configuration of the N RS configurations comprises one or more of the following:
a cell identifier, an RS configuration index, a cell specific reference signal (CRS) configuration, a non-zero power channel state information reference signal (NZP CSI-RS) configuration, a zero power (ZP) CSI-RS configuration, an EPDCCH start time, a multimedia broadcast multicast service single frequency network (MBSFN) subframe configuration, and a carrier frequency index.
5. The method according to claim 1, wherein notifying the UE of the correspondence between the M PRB sets and the N RS configurations comprises:
when each PRB set of the M PRB sets comprises a PRB set index, and each RS configuration of the N RS configurations comprises an RS configuration index, sending to the UE, second indication signaling which is used to indicate the correspondence between the M PRB sets and the N RS configurations, wherein the second indication signaling comprises the PRB set index of each PRB set of the M PRB sets and an RS configuration index corresponding to the PRB set index of each PRB set of the M PRB sets; or
when each PRB set of the M PRB sets comprises a PRB set index, sending to the UE, second indication signaling which is used to indicate the correspondence between the M PRB sets and the N RS configurations, wherein the second indication signaling comprises the PRB set index of each PRB set of the M PRB sets and an RS configuration corresponding to the PRB set index of each PRB set of the M PRB sets.
6. A method for processing an enhanced physical downlink control channel (EPDCCH), the method comprising:
acquiring, from a network-side device, M physical resource block (PRB) sets used for EPDCCH transmission, N reference signal (RS) configurations used for EPDCCH downlink control information (DCI) rate matching andor EPDCCH resource mapping, and correspondence between the M PRB sets and the N RS configurations, wherein N is a positive integer greater than 1, and M is a positive integer; and
performing EPDCCH detection on the M PRB sets respectively according to each PRB set of the M PRB sets and an RS configuration corresponding to each PRB set.
7. The method according to claim 6, wherein before performing EPDCCH detection on the M PRB sets respectively according to each PRB set of the M PRB sets and an RS configuration corresponding to each PRB set, the method further comprises:
performing quasi colocation (QCL) hypothesis on each PRB set of the M PRB sets.
8. The method according to claim 6, wherein the correspondence between the M PRB sets and the N RS configurations comprises that the M PRB sets correspond to the N RS configurations in a one-to-one manner.
9. The method according to claim 7, wherein performing QCL hypothesis on each PRB set of the M PRB sets comprises:
performing the QCL hypothesis according to the RS configuration corresponding to each PRB set of the M PRB sets.
10. The method according to claim 6, wherein each RS configuration of the N RS configurations comprises one or more of the following:
a cell identifier, an RS configuration index, a cell specific reference signal (CRS) configuration, a non-zero power channel state information reference signal (NZP CSIRS) configuration, a zero power (ZP) CSI-RS configuration, an EPDCCH start time, a multimedia broadcast multicast service single frequency network (MBSFN) subframe configuration, and a carrier index.
11. A network-side device, comprising:
a notifying unit, configured to notify a user equipment (UE) of M physical resource block (PRB) sets used for enhanced physical downlink control channel (EPDCCH) transmission and N reference signal (RS) configurations used for EPDCCH downlink control information (DCI) rate matching andor EPDCCH resource mapping, and notify the UE of correspondence between the M PRB sets and the N RS configurations, wherein N is a positive integer greater than 1, and M is a positive integer; and
a mapping unit, configured to perform the EPDCCH DCI rate matching andor the EPDCCH resource mapping according to the correspondence between the M PRB sets and the N RS configurations.
12. The network-side device according to claim 11, further comprising:
a determining unit, configured to determine at least one RS configuration of the N RS configurations, wherein the mapping unit is configured to perform the EPDCCH DCI rate matching andor the EPDCCH resource mapping according to the at least one RS configuration and a PRB set corresponding to the at least one RS configuration.
13. The network-side device according to claim 11, wherein the correspondence between the M PRB sets and the N RS configurations comprises that the M PRB sets correspond to the N RS configurations in a one-to-one manner.
14. The network-side device according to claim 11, wherein each RS configuration of the N RS configurations comprises one or more of the following:
a cell identifier, an RS configuration index, a cell specific reference signal (CRS) configuration, a non-zero power channel state information reference signal (NZP CSIRS) configuration, a zero-power (ZP) CSI-RS configuration, an EPDCCH start time, a multimedia broadcast multicast service single frequency network (MBSFN) subframe configuration, and a carrier frequency index.
15. The network-side device according to claim 11, wherein:
when each PRB set of the M PRB sets comprises a PRB set index, and each RS configuration of the N RS configurations comprises an RS configuration index, the notifying unit is configured to send to the UE, second indication signaling which is used to indicate the correspondence between the M PRB sets and the N RS configurations, wherein the second indication signaling comprises an index identifier of the M PRB sets and index identifiers of the N RS configurations corresponding to the index identifier of the M PRB sets; or
when each PRB set of the M PRB sets comprises a PRB set index, the notifying unit is configured to send to the UE, second indication signaling which is used to indicate the correspondence between the M PRB sets and the N RS configurations, wherein the second indication signaling comprises an index identifier of the M PRB sets and the N RS configurations corresponding to the index identifier of the M PRB sets.
16. A user equipment, comprising:
an acquiring unit, configured to acquire, from a network-side device, M physical resource block (PRB) sets used for enhanced physical downlink control channel (EPDCCH) transmission, N reference signal (RS) configurations used for EPDCCH downlink control information (DCI) rate matching andor EPDCCH resource mapping, and correspondence between the M PRB sets and the N RS configurations, wherein N is a positive integer greater than 1, and M is a positive integer; and
a processing unit, configured to perform EPDCCH detection on the M PRB sets respectively according to each PRB set of the M PRB sets and an RS configuration corresponding to each PRB set.
17. The user equipment according to claim 16, wherein the processing unit is further configured to perform quasi colocation (QCL) hypothesis on each PRB set of the M PRB sets.
18. The user equipment according to claim 16, wherein the correspondence between the M PRB sets and the N RS configurations comprises that the M PRB sets correspond to the N RS configurations in a one-to-one manner.
19. The user equipment according to claim 17, wherein the processing unit is configured to perform QCL hypothesis according to an RS configuration corresponding to each PRB set of the M PRB sets.
20. The user equipment according to claim 16, wherein each RS configuration of the N RS configurations comprises one or more of the following:
a cell identifier, an RS configuration index, a cell specific reference signal (CRS) configuration, a non-zero power channel state information reference signal (NZP CSIRS) configuration, a zero-power (ZP) CSI-RS configuration, an EPDCCH start time, a multimedia broadcast multicast service single frequency network (MBSFN) subframe configuration, and a carrier index.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
What is claimed is:
1. A method of removing infectious agents from mammalian soft-tissue, said method comprising subjecting said soft-tissue to extraction with a medium comprising a supercritical fluid, thereby removing said infectious agents.
2. The method according to claim 1, wherein said infectious agent is a member selected from the group consisting of viruses, bacteria, mycobacteria, fungus, mycoplasma and prions.
3. The method according to claim 2, wherein said virus is a member selected from hepatitis virus, and human immune deficiency virus.
4. The method according to claim 2, wherein said prions are causative agents of spongiform encephelopathy.
5. The method according to claim 1, wherein said fluid is carbon dioxide.
6. The method according to claim 5, wherein the tissue is treated with about 100 to about 500 grams of supercritical carbon dioxidegram of tissue.
7. The method as claimed in claim 6, wherein the tissue is treated with carbon dioxide for a period determined as a function of carbon dioxide flow rate in order to permit passage of about 100 grams to about 500 grams of supercritical carbon dioxidegram of tissue.
8. The method according to claim 7, wherein the tissue is treated with carbon dioxide for a period determined as a function of carbon dioxide flow rate in order to permit passage of about 200 grams to about 400 grams of supercritical carbon dioxidegram of tissue.
9. The method according to claim 6, wherein the supercritical carbon dioxide is applied at a pressure between about 1107 Pa and about 5107 Pa.
10. The method according to claim 9, wherein the supercritical carbon dioxide is applied at a pressure between about 2107 Pa and 4107 Pa.
11. The method according to claim 6, wherein the supercritical carbon dioxide is applied at a temperature between about 40 C. and about 55 C.
12. The method of claim 1, wherein said supercritical fluid is selected from one or more compounds of the group consisting of fluorocarbons, and alkanes.
13. The method of claim 12, wherein said fluorocarbons is selected from one or more compounds of the group consisting of chlorodifluoromethane and trifluoromethane.
14. The method of claim 12, wherein said alkanes is selected from one or more compounds of the group consisting of ethylene, propane and ethane.
15. The method of claim 12, wherein said critical, supercritical or near critical fluid is selected from one or more compounds of the group consisting of nitrous oxide, nitrogen and carbon dioxide.
16. The method according to claim 1, wherein said animal material is derived from an organ.
17. The method according to claim 1, wherein said mammalian soft-tissue is nerve tissue.
18. The method according to claim 1, wherein said mammalian soft-tissue is muscle tissue.
19. The method according to claim 1, wherein said mammalian soft tissue is adipose tissue.
20. The method according to claim 1, wherein said mammalian soft-tissue is glandular tissue.
21. A method according to claim 1, wherein said mammalian soft-tissue is epithelial tissue.
22. The method according to claim 1, wherein said mammalian soft-tissue is endothelial tissue.
23. The method according to claim 1, wherein said mammalian soft tissue is myocardial tissue.
24. The method according to claim 1, wherein said mammalian soft-tissue is vascular tissue.
25. The method according to claim 1, wherein said animal material is lymphatic tissue.
26. The method according to claim 1, wherein said animal material comprises respiratory tissue.
27. The method according to claim 1, wherein said animal material comprises digestive tissue.
28. The method according to claim 1, wherein said animal material comprises sensory tissue.
29. The method according to claim 1, wherein said animal material comprises urinary tissue.
30. The method according to claim 1, wherein said animal material comprises reproductive tissue.
31. The method according to claim 1, wherein said method further comprises adding a modifier or entrainer to said supercritical fluid.
32. The method according to claim 31, wherein said modifier or entrainer is a surfactant.
33. The method as in claim 31, wherein said modifier or entrainer is water.
34. The method according to claim 31, wherein said modifier or entrainer is an alcohol.
35. The method according to claim 34, wherein said alcohol is ethanol.
36. The method according to claim 34, wherein said alcohol is n-propanol.
37. The method according to claim 31, wherein said modifier or entrainer is a ketone.
38. A method as in claim 37, wherein said ketone is acetone.
39. A method of treating a mammalian soft tissue with a chemical agent, said method comprising contacting said tissue with a solution of said chemical agent in a supercritical fluid.
40. The method according to claim 39, wherein said chemical agent is a fixing agent.
41. The method according to claim 40, wherein said fixing agent is an aldehyde.
42. The method according to claim 41, wherein said aldehyde is glutaraldehyde.
43. A method for removing a chemical agent from a tissue following treatment of said tissue with said chemical agent, said method comprising contacting said tissue with a supercritical fluid under conditions that remove said chemical agent from said tissue.
44. The method according to claim 1, wherein said infectious agent is selected from the group consisting of nucleic acids, lipids, proteins, and polysaccharides.